ADICET BIO INC. - COMMON STOCK

Adicet Bio Added to the Russell 2000® Index

28 июн 2021 07:00:00 Источник Nasdaq GlobeNewswire

Adicet Bio to Participate in Upcoming Investor Conferences

18 май 2021 16:10:00 Источник Nasdaq GlobeNewswire

Adicet Reports First Quarter 2021 Financial Results and Provides Business Updates

17 май 2021 07:01:00 Источник Nasdaq GlobeNewswire

Adicet Bio to Participate in Fireside Chat at the 7th Annual Truist Securities Life Sciences Summit

29 апр 2021 07:00:03 Источник Nasdaq GlobeNewswire

Adicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference

15 апр 2021 07:00:02 Источник Nasdaq GlobeNewswire

Adicet Bio Appoints Dr. Blake Aftab as Vice President of Research

13 апр 2021 07:00:00 Источник Nasdaq GlobeNewswire

Adicet Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

11 мар 2021 16:10:00 Источник Nasdaq GlobeNewswire

Adicet Bio Appoints Dr. Andrew Sinclair to its Board of Directors

04 мар 2021 16:01:00 Источник Nasdaq GlobeNewswire

Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

16 фев 2021 07:00:01 Источник Nasdaq GlobeNewswire

Adicet Bio to Participate in Upcoming Investor Conferences

11 фев 2021 07:00:01 Источник Nasdaq GlobeNewswire

Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement

10 фев 2021 07:51:22 Источник Nasdaq GlobeNewswire

Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

09 фев 2021 16:04:22 Источник Nasdaq GlobeNewswire

Adicet Bio to Participate in Upcoming Investor Conferences

07 янв 2021 07:00:00 Источник Nasdaq GlobeNewswire